Lannett Company, Inc. (LCI)

NYSE: LCI · IEX Real-Time Price · USD
1.60 0.00 (0.00%)
Jan 14, 2022 4:00 PM EST - Market closed

Company Description

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States.

The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages.

It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications.

The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution.

It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations.

The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies.

Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

Lannett Company, Inc.
Lannett Company Logo
CountryUnited States
Founded1942
IndustryPharmaceuticals
SectorHealth Care
Employees810
CEOTimothy Crew

Contact Details

Address:
9000 State Rd
Philadelphia, Pennsylvania 19136-1615
United States
Phone215 333 9000
Websitelannett.com

Stock Details

Ticker SymbolLCI
ExchangeNYSE
Fiscal YearJuly - June
Reporting CurrencyUS Dollars
CIK Code0000057725

Key Executives

NamePosition
Timothy C. CrewChief Executive Officer and Director
John KozlowskiVice President of Finance, Chief Financial Officer and Principal Accounting Officer
John M. AbtVice President and Chief Quality and Operations Officer
Samuel H. IsraelGeneral Counsel and Chief Legal Officer
Maureen M. CavanaughSenior Vice President and Chief Commercial Operations Officer
Kristie StephensChief Compliance Officer and Vice President of Regulatory Affairs
Grant BrockVice President of Operations

Latest SEC Filings

DateTypeTitle
Jan 7, 20224Statement of changes in beneficial ownership of securities
Dec 14, 20214Statement of changes in beneficial ownership of securities
Dec 14, 20214Statement of changes in beneficial ownership of securities
Dec 10, 2021DEF 14AOther definitive proxy statements
Dec 2, 20214Statement of changes in beneficial ownership of securities
Dec 1, 20214Statement of changes in beneficial ownership of securities
Nov 30, 20214Statement of changes in beneficial ownership of securities
Nov 16, 20214Statement of changes in beneficial ownership of securities
Nov 4, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 4, 20218-KCurrent report
View All SEC Filings